Brian McNamee

Chairman at CSL LIMITED

Net worth: 9 M $ as of 30/05/2026

70 year

62 connections

Health Technology

Consumer Services

Health Services

Profile

Dr. Brian A. McNamee, MD, is a Principal at Tarnagulla Ventures Pty Ltd. He is on the Board of Directors at Zenyth Therapeutics Ltd. Dr. McNamee was previously employed as an Independent Director by Gen-Probe, Inc., Chief Executive Officer, Executive Director & MD by CSL Ltd., President by ZLB Behring LLC, General Manager-Faulding Product Divisions by FH Faulding & Co. Ltd., and a Managing Director by Pacific Biotechnology Ltd. He also served on the board at Gen-Probe, Inc. and Peter Maccallum Cancer Foundation Ltd. He received his undergraduate degree from the University of Melbourne and a doctorate degree from the University of Melbourne.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CSL LIMITED 0.03%	16/02/2026	127,628 ( 0.03% )	9 M $	30/05/2026

Brian McNamee active positions

Companies	Position	Start
ZENYTH THERAPEUTICS LIMITED	Director/Board Member	-
CSL LIMITED	Chairman	16/10/2018
Geoff Ogilvy Foundation	Chairman	30/04/2021
CSL Behring LLC CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products	Chairman	-

All active positions of Brian McNamee

Former positions of Brian McNamee

Companies	Position	End
Genesis Care Pty Ltd. Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services	Chairman	31/05/2022
CSL Behring LLC CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products	President	30/06/2013
CSL LIMITED	President	30/06/2013
Gen-Probe, Inc. Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis	Director/Board Member	30/05/2007
Tarnagulla Ventures Pty Ltd. Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements.	Private Equity Investor	-

See the detail of Brian McNamee's experience

Training of Brian McNamee

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brian McNamee's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
CSL Innovation Pty Ltd. CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
CSL Ltd. CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases	Health Technology
Gen-Probe, Inc. Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis	Health Technology
University of Melbourne University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
FH Faulding & Co. Ltd. FH Faulding & Co. Ltd. Pharmaceuticals: MajorHealth Technology Produces and wholesales pharmaceutical, household and allied products	Health Technology
CSL Behring LLC CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products	Health Technology
Pacific Biotechnology Ltd.
Genesis Care Pty Ltd. Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services	Health Services
Peter Maccallum Cancer Foundation Ltd.
Tarnagulla Ventures Pty Ltd. Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements.	Finance
Geoff Ogilvy Foundation